These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

520 related items for PubMed ID: 9829713

  • 1. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
    Hildesheim A, Schiffman M, Scott DR, Marti D, Kissner T, Sherman ME, Glass AG, Manos MM, Lorincz AT, Kurman RJ, Buckland J, Rush BB, Carrington M.
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
    [Abstract] [Full Text] [Related]

  • 2. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A, Schiffman MH, Tsukui T, Swanson CA, Lucci J, Scott DR, Glass AG, Rush BB, Lorincz AT, Corrigan A, Burk RD, Helgesen K, Houghten RA, Sherman ME, Kurman RJ, Berzofsky JA, Kramer TR.
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [Abstract] [Full Text] [Related]

  • 3. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK.
    APMIS Suppl; 1998 Oct; 80():1-41. PubMed ID: 9693662
    [Abstract] [Full Text] [Related]

  • 4. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women.
    Maciag PC, Schlecht NF, Souza PS, Franco EL, Villa LL, Petzl-Erler ML.
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1183-91. PubMed ID: 11097225
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. High-risk HPVs and risk of cervical neoplasia: a nested case-control study.
    Coker AL, Gerasimova T, King MR, Jackson KL, Pirisi L.
    Exp Mol Pathol; 2001 Apr; 70(2):90-5. PubMed ID: 11263952
    [Abstract] [Full Text] [Related]

  • 9. Human leukocyte antigen class II and cervical cancer risk: a population-based study.
    Madeleine MM, Brumback B, Cushing-Haugen KL, Schwartz SM, Daling JR, Smith AG, Nelson JL, Porter P, Shera KA, McDougall JK, Galloway DA.
    J Infect Dis; 2002 Dec 01; 186(11):1565-74. PubMed ID: 12447731
    [Abstract] [Full Text] [Related]

  • 10. Cervical carcinoma: human papillomavirus infection and HLA-associated risk factors in the Spanish population.
    Montoya L, Saiz I, Rey G, Vela F, Clerici-Larradet N.
    Eur J Immunogenet; 1998 Oct 01; 25(5):329-37. PubMed ID: 9805655
    [Abstract] [Full Text] [Related]

  • 11. HLA polymorphisms and cervical human Papillomavirus infection in a cohort of Montreal University students.
    Mahmud SM, Robinson K, Richardson H, Tellier PP, Ferenczy AS, Roger M, Coutlee F, Franco EL.
    J Infect Dis; 2007 Jul 01; 196(1):82-90. PubMed ID: 17538887
    [Abstract] [Full Text] [Related]

  • 12. Human leukocyte antigen class II alleles and risk of cervical cancer in China.
    Wu Y, Liu B, Lin W, Xu Y, Li L, Zhang Y, Chen S, Lin Z, Xu A.
    Hum Immunol; 2007 Mar 01; 68(3):192-200. PubMed ID: 17349874
    [Abstract] [Full Text] [Related]

  • 13. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity.
    Apple RJ, Erlich HA, Klitz W, Manos MM, Becker TM, Wheeler CM.
    Nat Genet; 1994 Feb 01; 6(2):157-62. PubMed ID: 8162070
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica.
    Hildesheim A, Herrero R, Castle PE, Wacholder S, Bratti MC, Sherman ME, Lorincz AT, Burk RD, Morales J, Rodriguez AC, Helgesen K, Alfaro M, Hutchinson M, Balmaceda I, Greenberg M, Schiffman M.
    Br J Cancer; 2001 May 04; 84(9):1219-26. PubMed ID: 11336474
    [Abstract] [Full Text] [Related]

  • 16. Polymorphisms of the human leukocyte antigen DRB1 and DQB1 genes and the natural history of human papillomavirus infection.
    Maciag PC, Schlecht NF, Souza PS, Rohan TE, Franco EL, Villa LL.
    J Infect Dis; 2002 Jul 15; 186(2):164-72. PubMed ID: 12134251
    [Abstract] [Full Text] [Related]

  • 17. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M, Benoy I, Simoens C, Bogers J, Beutels P, Depuydt C.
    Cancer Epidemiol Biomarkers Prev; 2009 Jan 15; 18(1):321-30. PubMed ID: 19124515
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. HPV-16 and HLA-DRB1 alleles are associated with cervical carcinoma in Mexican Mestizo women.
    Alaez-Verson C, Berumen-Campos J, Munguía-Saldaña A, Flores-Aguilar H, Guardado-Estrada M, Rodríguez-Gomez A, Gorodezky-Lauferman C.
    Arch Med Res; 2011 Jul 15; 42(5):421-5. PubMed ID: 21911185
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.